These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 651949

  • 21. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA, Reid PR.
    N Engl J Med; 1978 May 25; 298(21):1160-3. PubMed ID: 651945
    [Abstract] [Full Text] [Related]

  • 22. [Possibilities of drug therapy of arrhythmias in myocardial infarct].
    Kozená J, Kolár J.
    Cas Lek Cesk; 1971 May 25; 110(19):437-41. PubMed ID: 5574742
    [No Abstract] [Full Text] [Related]

  • 23. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan 08; 13(1):1-2. PubMed ID: 4104507
    [No Abstract] [Full Text] [Related]

  • 24. Lidocaine and procainamide toxicity during treatment of ventricular arrhythmias.
    Mattea J, Mattea E.
    Am J Nurs; 1976 Sep 08; 76(9):1429-31. PubMed ID: 1048862
    [No Abstract] [Full Text] [Related]

  • 25. A systemic lupus erythematosus-like syndrome induced by procainamide.
    Zeide MS, Wiesel S, Terry R, Stein D.
    Clin Orthop Relat Res; 1978 Sep 08; (134):290-2. PubMed ID: 729256
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Symposium on arteriosclerotic heart disease. Tachyarrhythmias. Differential diagnosis and therapy after acute myocardial infarction.
    Rubins S, Lozano J, Carrasco H, Lang TW, Corday E.
    Geriatrics; 1972 May 08; 27(5):123-33. PubMed ID: 5022803
    [No Abstract] [Full Text] [Related]

  • 28. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables.
    Fredrick DS, Boersma RB.
    Am J Hosp Pharm; 1979 Jun 08; 36(6):778-81. PubMed ID: 463893
    [Abstract] [Full Text] [Related]

  • 29. Dysrhythmia prophylaxis.
    Killip T.
    N Engl J Med; 1969 Dec 04; 281(23):1304-5. PubMed ID: 5349809
    [No Abstract] [Full Text] [Related]

  • 30. Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.
    Reidenberg MM, Drayer DE.
    Angiology; 1986 Dec 04; 37(12 Pt 2):968-71. PubMed ID: 2433971
    [Abstract] [Full Text] [Related]

  • 31. Pharmacologic basis for the treatment of cardiac arrhythmias.
    Gelband H, Rosen MR.
    Pediatrics; 1975 Jan 04; 55(1):59-67. PubMed ID: 1089243
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.
    Allen-Narker RA, Roberts CJ, Marshall AJ, Jordan SC, Barritt DW, Goodfellow RM.
    Br J Clin Pharmacol; 1984 Nov 04; 18(5):725-32. PubMed ID: 6439233
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Disopyramide in the prevention of arrhythmia following myocardial infarction and resistant arrhythmia].
    Dallocchio M, Daubeze J, Clementy J, Poisot D, Bricaud H, Broustet P.
    Therapie; 1974 Nov 04; 29(1):119-29. PubMed ID: 4848509
    [No Abstract] [Full Text] [Related]

  • 40. Prophylactic use of lidocaine in myocardial infarction.
    Med Lett Drugs Ther; 1976 Jan 02; 18(1):1-2. PubMed ID: 1105126
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.